Dopaminergic neuronal cell death, associated with intracellular α-synuclein (α-syn)-rich protein 74 aggregates (termed 'Lewy bodies'), is a well-established characteristic of Parkinson's disease. 75 Much evidence, accumulated from multiple experimental models has suggested that α-syn plays a 76 role in PD pathogenesis, not only as a trigger of pathology but also as a mediator of disease 77 progression through pathological spreading. Here we have used a machine learning-based approach 78 to identify unique signatures of neurodegeneration in monkeys induced by distinct α-syn pathogenic 79 structures derived from PD patients. Unexpectedly, our results show that, in non-human primates, 80 a small amount of singular α-syn aggregates is as toxic as larger amyloid fibrils present in the LBs, 81 thus reinforcing the need for preclinical research in this species. Furthermore, our results provide 82 evidence supporting the true multifactorial nature of PD as multiple causes can induce similar 83 outcome regarding dopaminergic neurodegeneration. 84 85 86 107 PD patients containing either soluble and small a-syn aggregates (hereafter named noLB) or LB-108 type aggregates (hereafter named LB). However, because of the unexpected finding that non-109 human primates, unlike mice, are susceptible to soluble or finely granular a-syn, we sought to 110 elucidate the response characteristics induced by either LB or noLB fractions. To achieve a 111 thorough analysis of these a-syn-related characteristics, we took advantage of the strength of 112 machine-learning algorithms for discovering fine patterns among complex sets of data and 113 developed a new method compatible with the constraints of experimental biology. We here report 114 the identification of primate-specific responses to selected a-syn assemblies associated with 115 different pathogenic mechanisms. Overall, our results support the concept of the multifactorial 116 nature of synucleinopathies.
INTRODUCTION
The seminal work of Braak and colleagues suggesting that Lewy body (LB) pathology follows a 89 predictable pattern of progression within the brain in Parkinson's disease (PD) (1) as well as the 90 'host-to-graft' observation (2-4) led to the development of experimental models based on injection 91 with a-synuclein (a-syn -the primary protein component of LB) assemblies (5-7). These 92 experimental models suggest that a-syn, in pathological conformations such as the one found in 93 LBs, initiates a cascade of events leading to dopaminergic neuron degeneration as well as cell-to- 94 cell propagation of a-syn pathology through a self-templating mechanism. 95 Several studies have suggested that pre-fibrillar oligomers may represent one of the major 96 neurotoxic entities in PD (8, 9) . This notion has been derived primarily from studies using large 97 doses of recombinant a-syn applied to cell cultures or injected into adult mice, over-expressing 98 either mutant or wild-type a-syn (10). In agreement with these findings, we have shown that 99 intracerebral injection of low doses of α-syn-containing LB extracts, purified from the substantia 100 nigra, pars compacta (SNpc) of postmortem PD brains, promotes α-syn pathology and 101 dopaminergic neurodegeneration in wild-type mice and non-human primates (11). Importantly, this 102 neuropathological effect was directly linked to the presence of a-syn in LB extracts, since immuno-103 depletion of α-syn from the LB fractions prevented the development of pathology following 104 injection into wild-type mice. 105 In this study, our aim was to thoroughly investigate this experimental model of synucleinopathy in 106 non-human primates. The initial study design was to administrate fractions derived from the same
RESULTS

120
Purification and characterization of α-synuclein extracts from PD patients 121 NoLB and LB fractions were obtained from the SNpc of five sporadic PD brains exhibiting 122 conspicuous LB pathology. The samples were processed through differential ultracentrifugation in 123 a sucrose gradient, and analyzed for the presence of α-syn aggregates by filter retardation assay 124 ( Fig. 1A) (11) . Further characterization of noLB and LB fractions was performed by co-localization 125 of α-syn and the amyloid dye Thioflavin S (Fig. 1B) as well as ultrastructural examination by 126 electron microscopy (Fig. 1C) . These assays confirmed the presence of misfolded a-syn in both 127 fractions. We also performed biochemical characterization of the stability of assemblies after 128 proteinase K digestion ( Fig. 1D ) and detergent treatments (Fig. 1E) followed by a-syn dot-blot 129 assays. While total α-syn content was comparable between selected fractions (as measured by α-130 syn ELISA), LB fractions showed higher resistance to proteinase K treatment (noLB 131 t1/2=15.23minutes vs LB t1/2>60minutes) ( Fig. 1D ) as well as greater resistance to multiple 132 detergents, including 8M Urea (Fig. 1E ). We then measured the content of a-syn aggregates using 133 human a-syn aggregation TR-FRET-based immunoassay, which revealed a significantly higher 134 amount of aggregated a-syn in LB fractions (Fig. 1F) . To obtain insight into the content of 135 monomeric and aggregated a-syn within noLB and LB fractions of PD patients, sarkosyl treatment 136 was applied to both fractions to induce physical separation, and then velocity sedimentation and 137 density floatation gradients were performed to quantify these two respective populations and 138 determine their relative abundance in each fraction ( Fig. S1 A-H) . Strikingly, while LB fractions 139 contained ~90% of aggregated a-syn, noLB fractions were composed of ~10% of this pathological 140 form of the protein (Fig. S1 I) . Also, in order to confirm the quality of the LB extraction, we 141 performed a filter retardation assay which showed that LB fractions, but not noLB fractions, were 142 highly enriched in known components of LBs, such as phosphorylated S129 a-syn, ubiquitin, p62, 143 hyperphosphorylated tau and Ab (Fig. S2 A) . 144 Micro-Infrared Spectroscopy of LB and noLB fractions was performed to show conformational 145 changes in amyloid structures at the molecular level ( Fig. S2 B-E) and this confirmed the presence 146 of b-sheet structures in both assemblies ( Fig. S2 B-C) . Although their velocity of sedimentation 147 and density floatation characteristics were similar, the aggregates present in the LB and noLB 148 fractions were different in nature based upon the evidence of Micro-Infrared Spectroscopy. 149 Principal component analysis (PCA) showed that, in the LB fractions, large aggregates 150 corresponding to the major pieces of LB were present (Fig. S2D , cluster on the right). PCA further 151 showed that, in the range of 1,590-1,700 cm -1 , the LB group contained a fraction of amyloid aggregates with different amyloid structures from those in the noLB group as they clearly 153 segregated by PCA in two clusters . Altogether, these results suggest that while LB 154 fractions primarily contained large aggregated a-syn fibrils, noLB fractions contained soluble a-155 syn and a smaller enrichment of a-syn aggregates featuring a specific amyloid structure not found 156 in the LB fractions. 157 Data from several studies suggest that both recombinant α-syn preformed fibrils (12) (13) (14) and 158 patient-derived α-syn (11) can promote pathogenic templating of endogenous a-syn ultimately 159 leading to dopaminergic neurodegeneration in SNpc. Following quantification by ELISA, both 160 mixes of fraction were diluted to ~24 pg a-syn per microliter. Then, those fractions were tested for 161 their pathogenic effects on TH-positive dopaminergic neurons in primary mesencephalic cultures 162 ( Fig. S3 A) as well as in vivo in wild-type mice. Four months after supranigral injection, LB-injected 163 mice displayed, as expected, significant dopaminergic degeneration, while noLB injections in mice 164 had no impact on dopaminergic neurons ( Fig. 1G -H) as we have previously reported for other 165 SNpc-derived LB fractions (11), thus validating the toxicity of the preparation prior to injection 166 into non-human primates. To determine the mechanisms of a-syn aggregates toxicity in a species closer to humans, adult 171 baboon monkeys (n=4-7 per experimental group) received bilateral stereotaxic injections (100µl) 172 of either LB or noLB fractions into the putamen before euthanasia 24 months post-injection. This 173 time-frame was chosen based on our previous studies indicating that after 14 months post-injection, 174 ongoing pathogenic effects can already be measured, and was extended to potentially reach disease-175 relevant lesions. Two years after administration, LB-injected monkeys displayed significant striatal 176 dopaminergic terminal loss both in the putamen and in the caudate nucleus, accompanied by a 177 significant decrease in tyrosine hydroxylase (TH) immunoreactivity in the substantia nigra pars 178 compacta (SNpc) (Fig. 2) . Stereological counts showed that LB-injected animals exhibited TH-179 positive and Nissl-positive cell loss in the SNpc (16% and 23%, respectively). No overt 180 parkinsonism was observed, however, since the extent of the lesion remained below the threshold 181 for symptom appearance; i.e. 45% of cell loss (15), compared to an age-matched control group. 182 At odds with mice either generated for the purpose of this study ( Fig. 1G-H) , previously published 183 (11), or produced in the context of other in-house studies (data not shown), noLB-injected monkeys 184 showed degeneration of the nigrostriatal pathway including dopaminergic cell loss (i.e. 16% of TH-positive neurons and 28% of Nissl-positive neurons quantified by stereology), similar to that 186 observed in LB-injected monkeys (Fig. 2 ). Facing such an unexpected finding, we aimed to identify 187 specific characteristics of the pathological mechanisms involved in a-syn toxicity induced by each 188 fraction independently, using a large-scale approach in combination with machine learning for 189 pattern identification.
191
Machine-learning algorithm predicts nigrostriatal degeneration 192 We performed an exploratory approach and aimed to distinguish relevant variables allowing 193 accurate prediction of neurodegeneration (i.e., to operate a feature selection). Overall, we Table S1 for exhaustive list of variables; Table S2 features all raw data). We first 198 extracted from this dataset, every variable that actually quantified neurodegeneration (i.e. 199 dopaminergic markers such as TH or dopamine transporter by immunohistochemistry), ending up 200 with 163 variables per animal. 201 Then, to operate feature selection, we designed a distributed algorithm using multiple layer 202 perceptron (MLP) (Bourdenx and Nioche, 2018), a classic machine-learning algorithm based on 203 artificial neural network that is able to approximate virtually any functions (Hornik et al., 1989) . 204 This algorithm was given, as input, the data obtained for each animal for the 163 aforementioned 205 variables and its output is a rank of these variables regarding their ability to predict three indicators 206 of dopaminergic tract integrity; that were levels of tyrosine hydroxylase staining in (i) the SNpc, 207 (ii) the putamen and (iii) the caudate nucleus. 208 The main difficulty was to overcome the large number of input variables (163) compared to the 209 sample size (n=4-7 per group), which can induce a selection and reporting bias (Kuncheva and 210 Rodriguez, 2018) . In order to tackle this "p > n" problem, instead of using a single network that 211 could be prone to overfitting, we put in competition several networks. 212 Each MLP was composed of a single hidden layer of 3 neurons ( Fig. 3C ). It has as input a subset 213 of 3 variables (out of the 163) and as output the 3 indicators of dopaminergic tract integrity. In total, 214 we used 708,561 sets of 3 inputs variables. Every instance of MLP was trained with 80% of our 215 sample (always a combination of control and injected animals) and tested on the remaining 20%. 216 The performance of each set of 3 input variables was evaluated according to the difference between 217 the predicted values of TH staining and the actual ones.
We focused on the top 1% of the best networks and counted the occurrence of each of the 163 219 variables in the subset of 3 variables used by these best networks (Fig. 3C ). We ranked each variable 220 according to the number of occurrences ( Fig. 3C ) for LB- (Fig. 3D ) and noLB-injected animals 221 ( Fig. 3E) independently. 222 In order to avoid possible overfitting, we used several methods in combination. First, we performed 223 cross-validation by splitting the dataset into two parts: a training and a testing set of data. 80% of 224 the data were randomly selected to train the networks (and independently for each network), while 225 the 20% remaining were used to evaluate the networks. Then, in order to evaluate the robustness of 226 the quality of prediction for a given set, we repeated this cross-validation step 50 times for every 227 set of 3 input variables (each network was trained and tested using a different partition of the dataset 228 -total number of network: 35,428,050). Lastly, we generated random data and used them as input 229 for the MLP. As expected, performances were significantly lower compared to our actual dataset 230 ( Fig. S4B , C). 231 Overall, this unique approach allowed us to rank input variables according to their explanatory 232 power and therefore to extract the strongest predictors of neurodegeneration for each experimental 233 group. Interestingly, despite similar levels of nigrostriatal degeneration between LB-and noLB-234 injected animals ( Fig. 2B) , the algorithm allowed us to identify differential variable sorting patterns Next, we compared the LB and noLB characteristics using the rank-rank hypergeometric overlap 239 (RRHO) test ( Fig. 4A ). Interestingly, low similarity was observed for the highly ranked variables 240 suggesting specific differences in the biological response to the injection of LB or noLB ( Fig. 4B ). 241 Focusing on the 20 first variables that showed low similarity between groups, we found that LB-242 exposed monkeys were characterized by both quantitative and qualitative changes in a-syn levels 243 (i.e. phosphorylation at Ser129 and aggregation) especially in cortical areas corroborated by distinct 244 methodologies as well as by a dysfunctional equilibrium in neurochemistry of basal ganglia output 245 structures classically associated with parkinsonism (16, 17) ( Fig. 4C -Fig. S5 ). Conversely, noLB-246 exposed monkeys exhibited more diverse nigrostriatal-centric characteristics with variables related 247 to a-syn aggregation, proteostasis and Zn homeostasis ( Fig. 4D -Fig. S6 ). Together, we identified 248 specific properties for both groups with limited overlap (35% -7/20 variables) for an identical level 249 of degeneration. 250 We next used a retrospective analysis to validates the relevance of the MLP-derived signature in 253 PD. Although, some variables have never been investigated in the context of PD, others have been 254 studied and reports exists in the literature. For instance, the amount of phosphorylated Ser129 α-255 synuclein in the entorhinal (h.psyn.ctx.er.ant) and parahippocampal (h.psyn.ctx.phipp) cortex -1 st 256 and 2 nd best predictors for the LB group -have been already associated with PD pathology. Studies 257 of post-mortem brains from PD patients revealed the presence of LB in these regions which was 258 correlated with disease progression(18) and predicted cognitive deficit in PD patients (19) . 259 Interestingly, the anterior entorhinal cortex has also been shown to be affected by severe α-syn reported by our group in an independent cohort of non-human primates (11). 264 Both LB and noLB signatures, and especially noLB, showed that variables related to a-syn 265 aggregation status were among the best predictors (LB: 1 in top10 best predictors; noLB 3 in top10 266 best predictors). This was highly expected from the literature as α-syn aggregation has been 267 associated with PD pathology (21). 268 Variables related to the proteostasis network (levels of the lysosomal receptor LAMP2 -269 wb.lamp2.sn -6 th or amount of ubiquinated proteins -wb.ub.sn -9 th ) were more specifically 270 associated with the noLB signature. This is of high interest as proteostasis defect is more and more 271 considered as a key step in pathogenicity (22) (23) (24) . 272 Levels of the microglia marker, IbaI, was ranked as the third best predictor of neurodegeneration 273 in the LB signature. Microglial inflammatory response was shown to be implicated in 274 neurodegeneration in many animal models, including α-syn overexpressing and toxin-based animal 275 model of PD (25). 276 Lastly, postmortem analysis of Zn 2+ concentration in the brains of PD patients has shown elevated 277 levels in the striatum and SNpc (26). Conversely, a recent meta-analysis showed a decrease of 278 circulating Zn 2+ levels in PD patients (27) . In experimental models of PD, Zn 2+ accumulation has 279 been associated with dopaminergic degeneration in rodent exposed to mitochondrial toxins (28, Experimental confirmation of MLPs' prediction 283 We aimed to confirm the relevance of the top first MLP selected variables. Since the LB signature 284 was associated with changes in a-syn phosphorylation in cortical areas, we analyzed side-by-side 285 the levels of a-syn and phosphorylated Ser129 a-syn in 18 brain regions ( Fig. 5A ). Interestingly, in agreement with the LB signature obtained from the MLP, LB-injected monkeys displayed a 287 stronger accumulation of phosphorylated Ser129 a-syn compared to noLB-injected animals (Fig. 288 5A-B). Also, the 2 most enriched variables of the LB signature (i.e. phosphorylated a-syn levels in 289 parahippocampal and entorhinal cortices ( Fig. 4C) ) showed significant negative correlations with 290 degrees of degeneration ( Fig. 5C-D) , thus confirming their ability to predict neurodegeneration. 291 Then, we decided to confirm the relevance of one of the strongest predictors, the levels of Zn 2+ in 292 the SNpc in independent experiments. First, we observed a significant increase of Zn 2+ in noLB- 293 injected mice compared to sham-injected or LB-injected mice (Fig. S7A ). Second, we analyzed the 294 levels of Zn 2+ in LB-injected macaque monkeys from a previous study of our laboratory (11). 295 Interestingly, despite the fact that these experiments were done in a different non-human primate 296 sub specie, injection of LB in the putamen (similar to the present study) or above the SNpc (different 297 from the present study) induced elevation of Zn 2+ levels in the SNpc, as measured by SR-XRF (Fig. 298 S7B). Of note, the dimension of the effect was similar across studies ( Fig. S7E ). Then, to 299 understand whether that modulation Zn 2+ levels was specific to our experimental paradigm, we 300 measured Zn 2+ levels in the context of adeno-associated virus-mediated overexpression of mutant 301 human a-syn in both rats and marmoset monkeys (30) using the same methodology ( Fig. S7C, D) . 302 Here, overexpression of a-syn did not triggered accumulation of Zn 2+ in the SNpc (despite inducing 303 dopaminergic neurodegeneration -(30) suggesting that this phenomenon is specific to seeding 304 experiment paradigms. 305 Lastly, we analyzed a publicly available cortical proteomic database of healthy individual and PD 306 patients. Of interest, we observed that several Zn 2+ transporters were elevated in the brains of PD 307 patients thus suggesting a zinc dyshomeostasis in patients ( Fig. S7F ). Indeed, plasma membrane 308 transporters such as the zinc transporter 1 (ZnT1), the Zrt-/Irt-like protein 6 (ZIP6) and ZIP10 309 showed increased levels ( Association metric shows independence of strong predictors 313 As we used combinations of 3 variables and because of the structure of MLPs, one could expect 314 that some combinations would complement each other to allow finer prediction of 315 neurodegeneration levels. To address this question, we used a classic measurement of association 316 in the field of data-mining: lift (31) and plotted the results as network plots showing association 317 (edge size) and enrichment in the best learners (node size). Lift calculation was corrected for error 318 prediction to avoid detrimental association between variables. The first observation was that the most enriched variables (top 3 to 5) appeared to be self-sufficient to predict the neurodegeneration 320 levels with minimal error (Fig. 6 ). Some variables, with modest enrichment, showed strong positive 321 associations that were specific to each experimental group. Associated variables in LB-injected 322 monkeys were: (i) α-syn-related parameters along the SNpc-striatum-cortex axis, an impairment of 323 locomotion and the ethologically-defined orientation of the animals towards their environment ( In the present study, we report that, in non-human primates, injection of distinct a-syn assemblies 335 derived from PD patients lead to dopaminergic degeneration through discrete mechanisms. 336 Applying a machine-learning method, we gained insight into unique signatures of degeneration 337 induced by injection of two distinct a-syn pathogenic assemblies (i.e. those contained in the LB 338 and noLB fractions derived from idiopathic PD patients' brains). To do so, we built a large dataset 339 with 180 variables obtained from behavioral, histological, biochemical, transcriptional and 340 biophysical approaches applied to several brain areas for each individual. By using a distributed 341 MLP algorithm that we developed for the purpose of this study, we identified characteristics that 342 give insight into the strongest predictors of neurodegeneration for each experimental group. We 343 have, therefore, described for the first time that distinct a-syn assemblies leading to similar 344 degeneration in monkeys are associated with different mechanisms, hence experimentally 345 confirming the true multifactorial nature of synucleinopathies. 346 Our results illustrate that both small oligomeric as well as larger a-syn assemblies induce 347 dopaminergic degeneration in non-human primates. This finding was unexpected, since previous 348 mouse studies from our laboratory showed that noLB injection did not have any observable 349 consequence regarding dopaminergic degeneration, a-syn accumulation or phosphorylation (11). 350 In agreement, other groups also showed the absence of toxicity of soluble recombinant a-syn (12).
One possible explanation is that primate dopaminergic neurons could be highly susceptible to a-352 syn toxicity. This could be in part due to their unique cellular architecture (32), a feature already 353 known to contribute to the selective vulnerability of these neurons in PD (33). In fact, the large and 354 complex axonal arbor of dopamine neurons make them particularly vulnerable to factors that 355 contribute to cell death and , in primates, this axonal arbor is ten-fold the size of that in rodents primate model for the study of synucleinopathies. 363 We also confirmed that the toxicity mechanisms associated with patient-derived a-syn aggregates 364 are shared features among patients and, therefore, common to the disease. Indeed, LB and noLB 365 fractions used in this study were isolated from a pool of 5 patients who were different from the pool 366 of 3 patients used in our previous study in mice (11) . In the mice experiment ( Fig. S3B ) performed 367 in this study, we observed the same level of dopaminergic degeneration (~40% at 4 months after 368 injection). 369 The surprising observation, in non-human primates, that the noLB fraction is toxic to the same 370 extent as the LB fraction suggests the existence of previously unrecognized forms of a-syn toxicity. 371 Several studies have suggested that pre-fibrillar oligomeric species are the toxic a-syn species (8, 372 9). Our biochemical studies showed that noLB and LB fractions had different amyloid properties 373 ( is due to a species common between LB and noLB. However, because of the extent of degeneration, 379 which was similar between the two experimental groups, and the a-syn content dissimilarity, both 380 in amount and nature, this appears very unlikely. We believe that our results support the notion of 381 the existence of a range of a-syn pathogenic structures with distinct toxic properties within the PD 382 brain. Further work is necessary to provide a complete structural characterization of those species. 383 As yet, very few studies report the high-resolution structures of a-syn aggregates, which are on the one hand, only derived from studies using recombinant a-syn and, on the other hand, limited to 385 near atomic resolution (35) (36) (37) . Encouragingly, much effort is currently being devoted to this field 386 of research and two recent studies reported the atomic structure of a-syn fibrils determined by cryo-387 electron microscopy (38, 39) , while still being limited to recombinant-generated a-syn, and not 388 isolated from human brain tissue. 389 In order to perform a characterization of the effects of the two fractions, we developed a machine 390 learning method to identify their biological characteristics. It is now well accepted that machine 391 learning algorithms can be trained to detect patterns as well as, or even better than, humans (40-392 42). Instead of the classification algorithms (the algorithm learns to identify in which category a 393 sample belongs) that were mostly used in recent applications of machine learning in biology (43), 394 we chose in this study to predict continuous and biologically-relevant variables using MLPs. Our 395 choice was motivated by the limited sample size that is often a constraint of experimental biology. 396 Although it might have been possible to use other feature selection methods, the use of MLPs with 397 a distributed architecture allowed us to avoid overfitting issues and to develop a method particularly 398 well-suited for low sample size datasets (44). As both LB and noLB-injected monkeys displayed 399 similar levels of degeneration, they were indistinguishable using that endpoint. Instead of using a 400 clustering analysis or a classification method, hence making the a priori assumption that these 401 groups where different, we preferred to submit the two experimental groups to the MLP 402 independently. 403 The combination of this constrained, distributed architecture and the holistic approach allowed us 404 to rank input variables according to the number of times they appeared in the group of best 405 predictors (defined as top 1% of best networks). A major issue in the use of machine learning in 406 experimental biology in the 'black-box' is the fact that it is usually impossible to 'understand' how 407 an algorithm predicted an output (45). By using a reverse engineering method, we aimed to tackle 408 that issue. Because we explored all possible combinations of our variables, we could rank the input 409 variables assuming that the more they appeared in the top 1%, the more they contained information 410 allowing precise prediction of the neurodegeneration levels. Interestingly, our two experimental 411 groups showed that some of the best predictors were similar (about 30%) but the majority were 412 different. One could hypothesize that the similar variables between the two signatures probably 413 embedded information that are consequences of neurodegeneration while the different ones 414 probably contain information regarding the process of disease initiation and/or progression. Further 415 experimental studies are now needed to confirm the relevance of these variables. 416 Also, as these two kinds of a-syn assemblies were associated with different signatures identified 417 by our MLP approach, we propose that our results illustrate the multifactorial nature of the disease 418 as different mechanisms (i.e. signatures) initiated by different triggers (i.e. a-syn assemblies) led 419 to similar consequences (i.e. degeneration levels). 420 Using this methodology, we confirmed the interest of highly-expected variables but more 421 importantly also unexpected variables that appear to be excellent predictors of a-syn-associated 422 dopaminergic degeneration. The first hit for LB-injected animals was phosphorylated a-syn in the 423 entorhinal cortex (as we have previously shown) followed by phosphorylated a-syn in the para-424 hippocampal cortex (unexpected), striatal microglial activation and GABA dysregulation in the 425 internal part of the globus pallidus (expected) (Fig. S5 ). Conversely, Zn homeostasis was a strong 426 predictive variable (unexpected) followed by a-syn aggregation-related terms (expected) in noLB-427 injected animals ( Fig. S6 ). 428 In order to confirm the prediction made by the MLP approach, we first performed a retrospective 429 literature analysis. This analysis showed that a significant part of the best predictors has been shown 430 in the literature to be correlated with disease progression. Then, we attempted to confirm the interest 431 of one of the top hits, the accumulation of Zn 2+ in the SNpc, in independent experimental cohorts. 432 Interestingly, we here describe that both in mice injected with noLB or in macaque monkeys (a 433 different non-human primate sub species that the baboons used in that study) injected either in the 434 striatum or in the SNpc, Zn levels were increased in the SNpc. However, in mice, Zn 435 dyshomeostasis was not associated with neurodegeneration in the noLB group (at odds with what 436 was observed in monkeys) suggesting a species difference in the relationship between zinc levels 437 and dopaminergic tract integrity. Surprisingly, that result was not observed in rats and marmoset 438 monkeys overexpressing human mutant a-syn. This observation might suggest that Zn 439 dyshomeostasis is a feature of disease not triggered in the context of human mutant a-syn 440 overexpression that is associated with fast progressing pathology (Bourdenx et al. 2015) . Then, in 441 order to expand our results to human pathology, we analyzed a publicly available proteomic dataset 442 of human samples. According to that analysis, PD patients displayed increased levels of plasma 443 membrane Zn transporters, hence suggesting a Zn dyshomeostasis in patients. In the context of PD, 444 Zn dyshomeostasis has been associated with autophagy/lysosomal dysfunction in the context of 445 PARK9 mutations (Ramirez et al. 2006 , Dehay et al. 2012 . Further studies are now needed to fully 446 unravel this connection. 447 Altogether, our findings show that primate dopaminergic neurons are sensitive to both small, mostly 448 soluble, a-syn extracts as well as larger, aggregated, a-syn extracts derived from PD patients. These 449 findings involve two immediate outcomes. First, since this toxicity has not been reported so far it 450 suggest species differences that would need to be thoroughly investigated (46, 47) and calls for a 451 systematic appraisal of proteinopathies in primates in particular for validating therapeutic strategies 452 before clinical testing (48) . Second, the present study highlights the complex structure-toxicity 453 relationship of a-syn assemblies and corroborates the multifactorial origin of synucleinopathies as 
MATERIALS AND METHODS
463
Access to data and machine-learning code for replicability and further use by the community 464 The entire raw data set is made available to the readers (Table S2 ). Authors chose not to provide 465 representative examples of each procedure for the sake of space and because the entire data set is Mice. Wild-type C57BL/6 mice (4 months old) received 2µl of either LB fractions or noLB 482 fractions by stereotactic delivery to the region immediately above the right substantia nigra 483 (coordinates from Bregma: AP=-2.9, L= -1,3, DV=-4.5) at a flow rate of 0.4µl/min and the pipette 484 was left in place for 5 min after injection to avoid leakage. Mice were killed four months after 485 injection. Ten to fifteen mice were used in each group. 486 Monkeys. Animals, whuch were from the research animal facility of the University of Murcia 487 (Murcia, Spain) and housed in 2 multi-male multi-female exterior pens, were studied in a breeding 488 farm over 2 years (Murcia, Spain). Animals were fed fruits, vegetables and monkey pellets twice a 489 day before 9 am and after 5pm. Water was available ad libitum. 17 healthy adult olive baboons 490 (Papio papio) were used in this study. Group sizes were chosen assuming a one-tailed alpha of 0.05, 491 with sample size of at least three per group, which provided >80% power to detect a difference 492 between the treatment groups and the control group, using a Fisher's exact test. Animals were 493 randomized into treatment or control groups. Six baboons were used for LB injections, four were 494 used for noLB injections and seven were untreated control animals. Intrastriatal injections of either LB fractions or noLB fractions were performed at 2 rostrocaudal levels of the motor striatum 496 (anterior commissure [AC], -1mm and -5mm) under stereotactic guidance as previously described 497 (49) (50) (51) (52) . The total injected volume per hemisphere was 100µl (2 injection sites with 50µl each at 498 3µl/min at each location site). After each injection, the syringe was left in place for 10 min to 499 prevent leakage along the needle track. A number of parameters were monitored during the course 500 of the two-year study, including survival and clinical observations. At the end of the experiment 501 (24 months post-injection), all monkeys were euthanised with pentobarbital overdose (150mg/kg 502 i.v.), followed by perfusion with room-temperature 0.9% saline solution (containing 1% heparin) 503 in accordance with accepted European Veterinary Medical Association guidelines. Brains were 504 removed quickly after death. Each brain was then dissected along the midline and each hemisphere 505 was divided into three parts. The left hemisphere was immediately frozen by immersion in 506 isopentane at -50°C for at least 5 min and stored at -80°C. The right hemisphere was fixed for one 507 week in 10 vol/tissue of 4% paraformaldehyde at 4°C, cryoprotected in two successive gradients of 508 20 then 30% sucrose in phosphate buffered saline (PBS) before being frozen by immersion in 509 isopentane (-50°C) for at least 5 min and stored at -80°C until sectioning. CSF and blood samples 510 (plasma, serum, whole blood) in the 17 animals were carefully collected before euthanasia. No 511 samples were excluded from analysis in these studies. Boehringer Mannheim) with 12 strokes of a motor-driven glass/teflon dounce homogenizer. For 527 LB purification, a sucrose step gradient was prepared by overlaying 2.2 M with 1.4 M and finally 528 with 1.2 M sucrose in volume ratios of 3.5:8:8 (v/v). The homogenate was layered on the gradient and centrifuged at 160,000 x g for 3 h using a SW32.1 rotor (Beckman). Twenty-six fractions of 530 1500 μl were collected from each gradient from top (fraction 1) to bottom (fraction 26) and analyzed 531 for the presence of α-synuclein aggregates by filter retardation assay, as previously described (11). 532 Further characterization of LB fractions was performed by immunofluorescence, α-synuclein 533 ELISA quantification and electron microscopy as previously described (11) 546 Electron microscopy. Briefly, carbon-coated nickel grids were covered for 1 min with 547 corresponding fractions of interest, then washed 3 times with distilled water. They were then 548 washed again in distilled water and stained for 5 min with 2% uranyl acetate, before being air-dried. 549 Digital images were obtained with a computer linked directly to a CCD camera (Gatan) on a Hitachi 550 H-7650 electron microscope. In all cases, samples were bath-sonicated for 5 min prior to the in 551 vitro applications. 552 Immunofluorescence analysis of noLB and LB fractions. Indicated fractions from the sucrose 553 gradient were spread over slides coated with poly-D lysine and fixed with 4% paraformaldehyde 554 (PFA) in PBS for 30 min. Fixed slides were stained with 0.05% thioflavin S for 8 min and then 555 washed three times with 80% EtOH for 5 min, followed by two washes in PBS for 5 min. Finally, 556 all samples were washed 3 times with PBS and blocked with 2% casein and 2% normal goat serum 557 for 30 min. For immunofluorescence analyses, samples were incubated with human α-synuclein 558 specific antibody (clone syn211, Thermo Scientific, 1:1000) for 30 min, washed three times with 559 PBS, incubated with a goat anti-mouse TRITC (Jackson, 1:500), before being cover-slipped for 560 microscopic visualization using fluorescence mounting medium. 561 Dot-blotting analysis. To evaluate PK-resistant α-synuclein contained in noLB and LB fractions 562 derived from PD brains, each fraction was subjected to digestion with 1 µg/ml proteinase K for 0, 15, 30, 45, and 60 min. The reaction was stopped by boiling for 5 min before dot-blotting with 564 syn211 antibody. To analyze their stability, noLB and LB fractions were treated with increasing 565 concentrations of urea (7 and 8M) or sodium dodecyl sulfate (SDS) (0.5, 1 and 2%) for 6 h at room 566 temperature. α-Synuclein was visualized as described above. 567 Filter retardation assay of noLB and LB fractions were probed with antibodies against, 568 phosphorylated α-synuclein (Abcam EP1536Y, 1:1000), ubiquitin (Sigma-Aldrich U5379, 1:1000), 569 p62 (Progen GR62-C, 1:1000), hyperphosphorylated tau (AT8, MN1020, ThermoFischer) or Ab 570 (DAKO clone 6F/3D, 1:1000). Postnatally derived ventral midbrain cultures were prepared essentially as previously described 620 (55) . Briefly, cultures were prepared in two steps. In the first step, rat astrocyte monolayers were 621 generated as follows. The entire cerebral cortex from a single rat pup (postnatal days 1-2) was 622 removed, diced, and then mechanically dissociated by gentle trituration. The isolated cells were 623 plated at 80,000 cells per well under which a laminin-coated coverslip was affixed. The cells were 624 housed at 37°C in an incubator in 5% CO2 and were fed on glial media (89% MEM, 9.9% calf 625 serum, 0.33% glucose, 0.5 mM glutamine, and 5 μg/mL insulin). Once confluence had been attained 626 (about 1 week in vitro), fluorodeoxyuridine (6.7 mg/mL) and uridine (16.5 mg/mL) were added to 627 prevent additional proliferation. In the second stage, which occurred 1 week later, rat pups aged 628 between 1 and 2 days were anesthetized and 1-mm 3 blocks containing ventral midbrain neurons 629 were dissected from 1-mm-thick sagittal sections taken along the midline of the brain. Tissues were 630 collected immediately into cold phosphate buffer and were treated enzymatically using papain (20 U/mL) with kynurenate (500 μM) at 37°C under continuous oxygenation with gentle agitation for 632 2 h. A dissociated cell suspension was achieved by gentle trituration and was then plated onto the 633 preestablished glia wells at a density of 0.5-1.7 million neurons per well. Cultures were maintained 634 in specially designed neuronal media (47% MEM, 40% DMEM, 10% Hams F-12 nutrient medium, 635 1% calf serum, 0.25% albumin, 2 mg/mL glucose, 0.4 mM glutamine, 10 μg/mL catalase, 50 μM 636 kynurenic acid, 10 μM CNQX, 25 μg/mL insulin, 100 μg/mL transferrin, 5 μg/mL superoxide 637 dismutase, 2.4 μg/mL putrescine, 5.2 ng/mL Na2SeO3, 0.02 μg/mL triiodothyronine, 62.5 ng/mL 638 progesterone, and 40 ng/mL cortisol) containing 27 μM fluorodeoxyuridine and 68 μM uridine to 639 control glial outgrowth and in 10 ng/mL glial cell derived neurotrophic factor (GDNF). They were 640 incubated for a further 7-8 days until the start of experiments. All tyrosine hydroxylase (TH) 641 neurons were counted on each plate following the addition of noLB and LB fractions after 1, 2, 5 642 and 7 days of treatment. were performed to avoid missing data. A unique trained observer (SC; intra-observer reliability: 653 Spearman rank order correlation R=0.987) collected the data live on the 2-time points of the study: 654 at 1-and 24-months post-surgery. The observer was standing 1 m away from the outdoor cages. 655 We focused on behavioral profiles rather than single items and used two repertoires: one reports 656 the interaction with the environment and one describes the position within the environment, 657 according to published protocols (57-59). We investigated the percentages of occurrence of each 658 item with regard to the total number of scans in order to obtain mean behavioral and postural time 659 budgets, body orientation and location profiles. immunostaining as we previously reported (11, 30) . Briefly, selected sections at two rostro-caudal 685 levels were incubated in a same well to allow direct comparison of immunostaining intensity. 686 Sections were incubated overnight at room temperature with the aforementioned antibodies. The 687 following day, revelation was performed with anti-specie peroxidase EnVision system (DAKO) 688 followed by 3,3′ -diaminobenzidine (DAB) incubation. Sections were then mounted on gelatinized 689 slides, dehydrated, counterstained if necessary and coverslipped until further analysis. Grey level 690 quantification or immunostaining-positive surface quantification in forty brain regions (Fig. 2B ) 691 were performed as previously described (30). for the microglial staining (dilution 1:1000). These signals were reveled with anti-specie peroxidase 698 EnVision system (DAKO) followed by DAB incubation. Sections were mounted on slides, counter-stained in 0.1% cresyl violet solution, dehydrated and cover-slipped. Sections stained by GFAP-S-700 100 were numerized at x20 magnification with a NanoZoomer (Hamamatsu, France) and the 701 quantification of GFAP-positive astrocytic reaction was estimated by a immunostaining-positive 702 surface quantification at regional levels with the Mercator software (ExploraNova, France). 703 Sections stained by Iba1 were used for the microglial morphology analysis through fractal 704 dimension quantification based on microscopic acquisitions, as previously described(60). All 705 analyses were performed blinded to the researcher. For the determination of the reference gene, the Genorm method was used(63). Relative expression 718 analysis was corrected for PCR efficiency and normalized against two reference genes. The 719 proteasome subunit, beta type, 6 (Psmb6) and eukaryotic translation initiation factor 4a2 (EIF4A2) 720 genes were used as reference genes. The relative level of expression was calculated using the 721 comparative (2 -∆∆CT ) method (63) and a ratio of signal on loading per animal was performed and used in statistical analyses.
Characterization of noLB and LB fractions
763
Dot-blot analysis of α-synuclein. This technique was performed as we previously described (9, 11) . 764 After heating at 100 °C for 5 min, 20 μg of protein extract was diluted in buffer (25 mM Tris-HCl, 765 200 mM Glycine, 1% SDS) and filtered through either a nitrocellulose membrane or an acetate 766 cellulose membrane (Bio-Rad, 0.2 μm pore size). Membranes were then saturated in 5% dry-skimmed milk in PBS and probed with antibodies against α-synuclein (syn211, 1:1000), both α-768 synuclein fibrils and α-synuclein oligomers (Syn-O1, 1:10000(65, 66)) (kindly provided by Prof.
769
Omar El-Agnaf). Revelation was done as described in the previous Materials and Methods section. (Jones, 2001; Walt, 2011; Hunter, 2007 (eigenvectors) that carry the underlying spectral information and in a Score plot that shows the 865 relation between spectra and can be used to cluster the data based on the spectral information. PCA 866 were performed in The UnscramblerX 10.3 (Camo Software) using the SVD algorithm with 867 leverage correction. Two series of preprocessing were applied prior to PCA and compared. Spectra were either baseline corrected in the amide I region between 1590 and 1700 cm -1 and vector 869 normalized, or their second derivatives were computed and vector normalized. 
